Mon, May 15, 2023

Graig Suvannavejh Maintained (ATHA) at Strong Buy with Decreased Target to $5 on, May 15th, 2023

Graig Suvannavejh of Mizuho, Maintained "Athira Pharma, Inc." (ATHA) at Strong Buy with Decreased Target from $6 to $5 on, May 15th, 2023.

Graig has made no other calls on ATHA in the last 4 months.



There are 2 other peers that have a rating on ATHA. Out of the 2 peers that are also analyzing ATHA, 0 agree with Graig's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Graig


  • Thomas Shrader of "BTIG" Maintained at Strong Buy with Decreased Target to $10 on, Thursday, March 30th, 2023
  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $20 on, Friday, March 24th, 2023